Cardiologist Yerem Yeghiazarians, MD, and molecular cancer biologist Kurosh Ameri, PhD founded Soley Therapeutics in 2020, but their unique cardio-oncological interdisciplinary collaboration spans more than a decade. Together they built a proprietary understanding of how cells sense stress and respond to molecules or drugs, which in turn dictates cell fate.

The study of cells as biosensors is increasingly recognized as a critical component of our understanding and treatment of diseases. Two Nobel Prizes were awarded in this field for the discovery of different cellular sensing pathways in 2019 and 2021 respectively.